NCT02120664View on ClinicalTrials.gov

Florbetapir Calibration to the Centiloid Scale

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Alzheimer's Disease
Interventions
DRUG

Florbetapir (18F)

DRUG

11C-PiB

Trial Locations (2)

3084

Research Site, Heidelberg

15213

Research Site, Pittsburgh

Sponsors
All Listed Sponsors
lead

Avid Radiopharmaceuticals

INDUSTRY